News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sirnaomics Names China Partner for siRNA Therapeutic


6/23/2011 3:41:37 PM

June 23, 2011 -- Sirnaomics, located in Maryland, USA, has partnered with Guangdong Zhongsheng Pharmaceutical Co. to develop its small interfering RNA (siRNA) ocular neovascularization therapeutic. The partnership will seek to develop and commercialize STP601, a Sirnaomics siRNA candidate for treatment of diabetic retinopathy and age-related macular degeneration. Zhongsheng Pharma is committing 63 million RMB ($9.8 million) to the partnership, including upfront and milestone payments. More details....

Stock Symbol: (SZE: 002317)


Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES